[Statins as a new therapeutic possibility in osteoporosis? Wishful thinking as opposed to data].
Barthel
H R
HR
D001205:Ascorbic Acid / Q000627:therapeutic use; D015992:Body Mass Index; D015519:Bone Density; D016022:Case-Control Studies; D015331:Cohort Studies; D003625:Data Collection; D050723:Fractures, Bone / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D001205:Ascorbic Acid
Statine als neue Therapiemöglichkeit der Osteoporose? -Wunschdenken im Kontrast zur Datenlage.